EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia

Journal article

Peer reviewed

H Alabdulkarim, H Almodaimegh, L C Abu Esba, Y Sharma, S Attar, W Hussain, I Alhomood, B A Al-Omari, O Mohamed, M Alsaqa’aby, …

Value in health, Vol.25(7), p.S407

07/2022

Metrics

1 Record Views

Title: EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia
Creators - without role: H Alabdulkarim
H Almodaimegh
L C Abu Esba
Y Sharma
S Attar
W Hussain
I Alhomood
B A Al-Omari
O Mohamed
M Alsaqa’aby
A Roshdy
A Anwar
T Hamad
Z Alzahrani
Publication Details: Value in health, Vol.25(7), p.S407
Identifiers: 9921196708331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article